ReviveMed’s AI unlocks hidden disease clues for precision medicine
AZoRobotics - 06-Mar-2025Using metabolomics and AI, this MIT spinout is transforming drug development and treatment
Join the club for FREE to access the whole archive and other member benefits.
Company discovering, developing and delivering innovative medicines to patients with serious diseases.
Through the Bristol-Myers Squibb Foundation, we promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world’s most vulnerable people. Each day, our employees around the world work together for patients – it drives everything we do.
Our medicines are helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience, fibrosis and others. We have built a sustainable pipeline of potential therapies, and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient at the right time to achieve the best outcome.
Visit website: https://www.bms.com/
Details last updated 25-Nov-2020
Using metabolomics and AI, this MIT spinout is transforming drug development and treatment
Giant leap towards developing transformative medicines powered by machine learning
A $2B partnership seeks to transform drug discovery with AI and stem cell models